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Abstract
To better understand the impact that nonresponse for specimen collection has on the validity of 
estimates of association, we examined associations between self-reported maternal 
periconceptional smoking, folic acid use, or pregestational diabetes mellitus and six birth defects 
among families who did and did not submit buccal cell samples for DNA following a telephone 
interview as part of the National Birth Defects Prevention Study (NBDPS). Analyses included 
control families with live born infants who had no birth defects (N = 9,465), families of infants 
with anorectal atresia or stenosis (N = 873), limb reduction defects (N = 1,037), gastroschisis (N = 
1,090), neural tube defects (N = 1,764), orofacial clefts (N = 3,836), or septal heart defects (N = 
4,157). Estimated dates of delivery were between 1997 and 2009. For each exposure and birth 
defect, odds ratios and 95% confidence intervals were calculated using logistic regression 
stratified by race-ethnicity and sample collection status. Tests for interaction were applied to 
identify potential differences between estimated measures of association based on sample 
collection status. Significant differences in estimated measures of association were observed in 
only four of 48 analyses with sufficient sample sizes. Despite lower than desired participation rates 
in buccal cell sample collection, this validation provides some reassurance that the estimates 
obtained for sample collectors and noncollectors are comparable. These findings support the 
validity of observed associations in gene-environment interaction studies for the selected 
exposures and birth defects among NBDPS participants who submitted DNA samples.
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1 Introduction
Appropriate generalization of results from gene-environment interaction studies requires that 
estimated measures of association obtained from the subgroup who collected specimens are 
similar to those from the larger study population. Self-selection bias can occur when 
participation rates are low and differ among subgroups for which different associations exist 
between the exposure and outcome, leading to inaccurate interpretation of results 
(Morimoto, White, & Newcomb, 2003).
Among families eligible for the National Birth Defects Prevention Study (NBDPS), 37% of 
case and 31% of control families provided both interview data and buccal (cheek) cell 
samples for at least one family member. In addition to decreased power that results from 
suboptimal participation rates, there is concern about self-selection bias given the 
documented differences in submitting buccal cell samples based on demographic, lifestyle, 
or other factors (Crider, Reefhuis, Woomert, & Honein, 2006; Glidewell et al., 2014).
The main public health impact of NBDPS genetic analyses is to identify gene-environment 
interactions that might provide the opportunity for prevention. We assessed associations 
between maternal periconceptional smoking, periconceptional use of vitamins containing 
folic acid, and pregestational diabetes mellitus, type 1 or 2 (diabetes), and six selected birth 
defects using tests of interaction to determine whether participation in sample collection 
among NBDPS participants impacted the observed associations.
2 Methods
2.1 Study population
The NBDPS is a population-based case-control study of genetic and nongenetic risk factors 
for major structural birth defects conducted in 10 states (Arkansas, California, Georgia, 
Iowa, Massachusetts, New Jersey, New York, North Carolina, Texas, and Utah) (Reefhuis et 
al., 2015). Eligible infants had at least one of approximately 30 structural birth defects (case 
infants) or no major birth defects (control infants). Case infants were ascertained from 
existing population-based surveillance systems and could be live born, stillborn, or 
terminations. Clinical geneticists reviewed medical records using standard case definitions to 
determine eligibility (Rasmussen et al., 2003). Infants with chromosomal abnormalities or 
single gene disorders were excluded. Live born control infants were selected randomly from 
birth certificates or birth hospital data from the same geographic region and time period. A 
computer-assisted telephone interview was conducted with mothers between 6 weeks and 24 
months after their estimated date of delivery (EDD) to collect information on pregnancy 
exposures, including information on periconceptional (between 1 month before and the first 
3 months of pregnancy) maternal smoking, folic acid use, and diabetes. Interviews were 
conducted in English or Spanish after obtaining verbal consent. Following completion of the 
interview, mothers were sent cytobrushes (two per participant) to collect buccal cell samples 
from themselves, their infant (if living), and their infant's biological father. Institutional 
Review Boards at the Centers for Disease Control and Prevention and each study site 
approved the NBDPS.
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Families of infants with one or more of six birth defects (neural tube defects (NTDs), 
orofacial clefts, gastroschisis, limb reduction defects, anorectal atresia/stenosis, or septal 
heart defects) and control families with EDDs between 1997 and 2009, who had completed 
all or part of the maternal interview, and either did (sample collector) or did not (sample 
noncollector) provide buccal cell samples from the mother, infant, or both were included. 
Infants with more than one of the selected birth defects were included in multiple case 
groups. Eligible case infants could have other birth defects in addition to the six under study. 
One mother who provided samples for herself reported using an egg donor, and her data 
were removed from analyses of sample collectors. Selected exposures and birth defects were 
chosen based on their use in NBDPS gene-environment interaction studies, sample sizes, 
and previous reported associations (Cleves, Hobbs, Zhao, Krakowiak, & MacLeod, 2011; 
Correa et al., 2008; Hackshaw, Rodeck, & Boniface, 2011; Hobbs et al., 2014; Jenkins et al., 
2014; Lupo et al., 2012; Tang, Cleves et al., 2015; Tang, Hobbs et al., 2015). We considered 
the associations between three exposures and six phenotypes to assess whether sample 
collection participation impacts the observed associations over a range of sample sizes.
2.2 Statistical analyses
Genetic analyses are typically stratified by race-ethnicity due to differences in minor allele 
frequencies and genetic effects. Maternal race-ethnicity was used as a proxy for infant race-
ethnicity. Frequency distributions for each exposure and phenotype were calculated for 
sample collectors and noncollectors stratified by maternal race-ethnicity (non-Hispanic 
white (NHW), non-Hispanic black (NHB), and Hispanic), and differences were assessed 
using chi-square tests. We used logistic regression to calculate crude and adjusted (for 
continuous maternal age at delivery) odds ratios (ORs) and 95% confidence intervals (CIs) 
for each exposure and birth defect stratified by sample collection status and race-ethnicity. 
Maternal age at delivery (<25 years or ≥25 years) was also assessed as a potential effect 
modifier for gastroschisis analyses (Jones et al., 2016). Analyses of NTDs and each assessed 
exposure included additional potential confounders; maternal body mass index (<18.5; 18.5–
24.99; 25–29.99; ≥30), maternal education (≤12 years or >12 years), study site, 
periconceptional alcohol consumption (any or none), and each exposure that was not the 
main exposure of interest.
Tests of interaction were applied to identify differences between estimated measures of 
association of sample non-collectors and collectors for each exposure and birth defect 
according to the method of Altman and Bland (2003). A ratio of the ORs (OR of 
noncollectors/OR of collectors) and corresponding 95% CIs were calculated. P-values for 
interaction (Pint) were calculated from Z scores using a significance level of <0.05 and a 
two-tailed hypothesis. This method tests the null hypothesis of no significant difference 
between the two ORs by comparing the Z score to the standard normal distribution. To test 
for interaction, subgroups (and their effect estimates) must be independent. Thus, we 
compared estimates of sample noncollectors and collectors rather than comparing sample 
collectors to all those who completed an interview. Analyses were not conducted when 
stratum sizes fell below two participants. No adjustments to P-values for multiple 
comparisons were made to the primary analyses but were considered in sensitivity analyses 
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using the p.adjust function in the stats package of R (Benjamini & Hochberg, 1995). IBM 
SPSS Statistics Version 21.0 was used to analyze data in the primary analyses.
3 Results
3.1 Sample collection rates
Among control mothers who completed the interview, 4,522 women (48%) submitted 
samples for themselves (n = 157; 3%), their infant (n = 43; 1%), or both (n = 4,322; 96%) 
(Table 1). Among case mothers, sample collection rates differed by birth defect. Collection 
rates also differed by race-ethnicity. With few exceptions, case-control status significantly 
affected sample collection rates overall and when stratified by race-ethnicity.
3.2 Frequency distributions of selected exposures
Periconceptional smoking was reported less often and folic acid use more often in sample 
collectors compared to noncollectors with a few exceptions (Table 2). This difference was 
significant among NHW mothers of control infants and of four infant case groups for 
smoking, and among NHW mothers of infants with gastroschisis or anorectal atresia/
stenosis for folic acid use.
Diabetes was reported significantly more often in sample collectors compared to 
noncollectors among NHW mothers of infants with anorectal atresia/stenosis or septal heart 
defects and significantly less often in collectors compared to noncollectors among NHB 
mothers of infants with orofacial clefts (Table 2).
3.3 Measures of association and tests of interaction
No significant differences were observed between estimated measures of association from 
sample noncollectors and collectors for smoking and each birth defect when data were 
stratified by race-ethnicity (Table 3). Significant differences were observed between 
estimated measures of association from sample noncollectors and sample collectors for folic 
acid use among NHW mothers and their infants with gastroschisis or anorectal atresia/
stenosis (Table 4). Significant differences were also observed for diabetes among NHB 
mothers and their infants with orofacial clefts and among NHW mothers and their infants 
with septal heart defects (Table 5). Small numbers precluded some analyses of diabetes. 
Results for ORs (crude or age-adjusted) were similar for all analyses; adjusted ORs were 
reported.
Tests of interaction among families of infants with gastroschisis and smoking or folic acid 
use stratified by maternal age at delivery were completed for all three racial-ethnic groups 
(data not shown). Small numbers precluded completion of similar tests for diabetes. 
Significant differences between ORs from sample noncollectors and collectors were 
observed in analyses of folic acid use among older NHW mothers (Pint = 0.03) and were 
borderline among younger mothers (Pint = 0.07). Among older mothers, ORs were 
significantly reduced in sample noncollectors who reported folic acid use (OR = 0.36, 95% 
CI: 0.17, 0.77; P = 0.009) and consistent with the null in sample collectors (OR = 1.65, 95% 
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CI: 0.52, 5.30; P = 0.40). No significant differences were observed among families with 
NHB or Hispanic mothers.
Similar results were observed among families of infants with NTDs and each exposure after 
adjusting for additional confounders and adjusting for maternal age at delivery only (data 
not shown).
4 Discussion
Our data reduce concerns about the potential impact of selection bias due to sample 
collection in gene-environment interaction studies for selected birth defects (NTDs, orofacial 
clefts, gastroschisis, limb reduction defects, anorectal atresia/stenosis, and septal heart 
defects) and exposures (maternal periconceptional smoking, folic acid use, and diabetes) 
among NBDPS participants. No significant differences in estimated measures of association 
between sample noncollectors and collectors were observed in 44 of 48 analyses with 
sufficient sample sizes. Due to suboptimal response rates, it is difficult to claim that there is 
no selection bias; however, these findings might assuage concerns over different underlying 
estimates based on sample collection.
To our knowledge, no studies have assessed the potential effect of noncollection on the 
validity of estimated measures of association for gene-environment interaction studies. The 
goal of this paper was not to assess individual associations but differences between estimates 
of associations of sample collector and noncollector subgroups. The main effects of the 
exposures on birth defect risk do not have to be strong to assess these differences, and the 
exposures chosen for this study had varied effects. We used a statistical test of interaction 
(Altman & Bland, 2003) to compare these estimates with a null hypothesis of equal 
estimates.
With only one exception, no exposure distributions differed significantly by sample 
collection among families with NHB or Hispanic mothers. Among families with NHW 
mothers, nine of 21 distributions differed significantly by sample collection. However, only 
four of the 10 exposure and birth defect combinations that differed significantly by sample 
collection had significant interaction terms.
We observed four significant interaction terms out of 48 tests. If all 48 tests were 
independent and there was truly no interaction, the probability of at least one false positive is 
over 90%. Thus, it was unclear if the significant results were true differences or type I errors. 
To mitigate these concerns, we conducted false discovery rate analysis (Benjamini & 
Hochberg, 1995) and found no significant interaction terms (data not shown). Although 
multiple testing corrections cannot distinguish between individual false and true positive 
findings, they do reduce the inherent inflation of the false-positive rate due to repeated 
testing. However, because a lack of significant interactions was reassuring, investigators 
using NBDPS specimens and interview data might be well-served to assess selection bias for 
each exposure and outcome combination included in their analyses.
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Because maternal age is a strong risk factor for gastroschisis, analyses of maternal smoking 
or folic acid use were stratified by and adjusted for maternal age at delivery with similar 
results, suggesting that maternal age was not acting as an effect modifier.
Specimen nonresponse limits the ability to identify genetic variants with small to moderate 
effects that might interact with environmental factors to modify disease risk, more so than in 
other epidemiological research. These analyses assessed the impact of selection bias on 
estimates of association for environmental risk factors and did not directly assess the impact 
on gene-environment interactions. To expand our findings to gene-environment interactions 
assumes that there is limited genetic heterogeneity between sample collectors and 
noncollectors. Although we know from previous studies (Crider et al., 2006; Glidewell et al., 
2014; McQuillan, Porter, Agelli, & Kington, 2003; Moorman et al., 2004) that race and 
ethnicity are factors that consistently affect whether a participant collects and submits 
specimens, genetic studies typically stratify data by race and ethnicity to account for genetic 
heterogeneity during analyses. Other factors observed to affect collection of specimens for 
genetic research, such as age, income, and education, should have limited genetic 
heterogeneity between sample collectors and noncollectors. Challenges to assessing gene-
environment interaction using NBDPS data include relatively small numbers of infants with 
each birth defect, suboptimal sample collection rates, and self-reported exposure data 
collected up to 2 years after an infant's EDD. We considered combining case groups to 
increase statistical power. However, because the causes of birth defects are so varied, 
analyses with combined case groups would be of limited value to other etiological studies of 
birth defects. Although there were many exposures (e.g., other maternal health conditions, 
medications, other vitamins, diet, stress, alcohol, illicit drugs, maternal, and paternal 
occupation) and over 30 birth defects included in the NBDPS, we limited these analyses to 
associations between three exposures and six birth defects that were included in NBDPS 
gene-environment interaction studies to help inform future studies. The NBDPS is the 
largest birth defects risk factor study to collect biological specimens in the United States. It 
has a population-based, multi-state ascertainment that included participants who were 
representative of their base populations (Cogswell et al., 2009), specimen collection quantity 
and quality that improved over time (Gallagher et al., 2011), and clinicians who reviewed 
each case using standard definitions (Rasmussen et al., 2003). After establishing that 
nonresponse in buccal cell collection and submission was not a random event (Glidewell et 
al., 2014), there were some concerns over how representative risk estimates limited to 
sample collectors would be. This study allays concerns by showing that the majority of 
estimates for sample collectors and noncollectors are comparable, providing some 
reassurance as gene-environment interactions are assessed using NBDPS samples and 
interview data.
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